Skip to main content
main-content

Free registration

Medicine Matters is developed for healthcare professionals as

a premier resource for the latest clinical information in medicine.

Editor's pick

16-04-2019 | Small-cell lung cancer | News

CheckMate 451: Maintenance immunotherapy fails to improve SCLC survival

Maintenance treatment with nivolumab, either given alone or alongside ipilimumab, does not prolong the overall survival of patients with extensive-stage small-cell lung cancer, the CheckMate 451 investigators have found.

10-04-2019 | Urothelial cancer | Video | Article

Adjuvant chemotherapy for upper tract urothelial cancer

Dr Alison Birtle (Rosemere Cancer Centre, Royal Preston Hospital, UK) discusses the rationale for adjuvant chemotherapy for upper tract urothelial cancer (UTUC), the POUT trial and its practice-changing implications for treatment of UTUC.

20-03-2019 | Non-small cell lung cancer | Themed collection | Collection

CNS metastases in NSCLC

A themed content collection to help HCPs keep up to date with the latest developments in the area of CNS metastases arising from non-small-cell lung cancer, as well as consolidate knowledge of the risk factors and treatment options.

This collection was made possible by educational funding provided by AstraZeneca.

Conference coverage from the AACR Annual Meeting 2019

Click here for breaking news and expert interviews from the meeting in Atlanta (March 29–April 3, 2019).

Specialty

Latest from across the site

18-04-2019 | Non-small cell lung cancer | News

ABCP benefits shown in key NSCLC subgroups

Patients with nonsquamous non-small-cell lung cancer who have sensitizing EGFR mutations or liver metastases may benefit from the addition of atezolizumab to bevacizumab and chemotherapy, IMpower150 trial data show.

18-04-2019 | Prostate cancer | News

68Ga-PSMA-11 PET shows ‘high accuracy’ for localizing recurrent prostate cancer

Positron emission tomography using 68gallium-labeled ligands of the prostate-specific membrane antigen is accurate, reproducible, and safe in localizing biochemically recurrent prostate cancer, according to the results of a prospective trial.

17-04-2019 | Non-small cell lung cancer | News

Conflicting data reported on immunotherapy benefit for older NSCLC patients

The overall survival benefit of immunotherapy in elderly patients with advanced non-small-cell lung cancer is unclear according to two studies with contradictory results presented at the European Lung Cancer Congress 2019 in Geneva, Switzerland.

16-04-2019 | Small-cell lung cancer | News

CheckMate 451: Maintenance immunotherapy fails to improve SCLC survival

Maintenance treatment with nivolumab, either given alone or alongside ipilimumab, does not prolong the overall survival of patients with extensive-stage small-cell lung cancer, the CheckMate 451 investigators have found.

15-04-2019 | Complementary and alternative medicine | News

Guidance needed to encourage cancer patients, physicians to discuss CAM use

A third of cancer patients and survivors use complementary and alternative medicine, but they do not always disclose its use to their physicians, findings indicate.

12-04-2019 | Non-small cell lung cancer | News

ALK resistance mutations predict lorlatinib efficacy in NSCLC patients progressing on ALK–TKIs

Lorlatinib is more efficacious against non-small-cell lung cancer with versus without ALK resistance mutations in patients with disease progression after at least one second-generation ALK–tyrosine kinase inhibitor, suggests research.

Independent Medical Education

New options in metastatic pancreatic cancer: Interactive patient cases

Pancreatic cancer case studies
Independent Medical Education

Steering improved outcomes in non-driver mutation lung cancer: Progress and challenges

Steering improved outcomes in lung cancer

This program was made possible thanks to an independent educational grant from Eli Lilly and Company. Produced by Springer Healthcare Independent Medical Education.

Independent Medical Education

Gastric cancer care: From evidence to practice

Gastric cancer care

This program was made possible thanks to independent educational sponsorship from Eli Lilly and Company. Produced by Springer Healthcare Independent Medical Education.

Meet the Editorial Board


Our international Editorial Board members Dr Fiona Blackhall (Christie Hospital, Manchester, UK) and Dr Axel Merseburger (University Hospital Schleswig-Holstein, Germany) work closely with the editorial team to highlight gaps in coverage and select topics to feature on this digital platform.

Why register? Medicine Matters oncology is a free resource providing the latest news and clinical guidance

Register today and receive updates directly to your inbox!
Medicine Matters oncology has been specifically developed for the time-limited healthcare professional who is looking for a single resource providing credible information on current practice and the latest advances in oncology.
Already registered? Log in now to unlock your access.

Latest from us on Twitter

Updates from oncology organizations

New Content Item Meet our Advisory Board

image credits